Does ketamine or magnesium affect posttonsillectomy pain in children?

Area of Science:

• Pediatric Anesthesiology
• Pain Management
• Pharmacology

Background:

• Previous studies suggest N-methyl-D-aspartate (NMDA) receptor antagonists like ketamine and magnesium reduce postoperative pain in adults.
• However, their efficacy in pediatric populations for pain management remains largely uninvestigated.

Purpose of the Study:

• To evaluate the efficacy of ketamine and magnesium in reducing postoperative pain and analgesic requirements in children undergoing tonsillectomy.
• To investigate potential synergistic effects between ketamine and magnesium in pediatric pain management.

Main Methods:

• A randomized, double-blind, placebo-controlled trial involving 80 pediatric patients (aged 3-12 years) undergoing tonsillectomy.
• Patients received intravenous ketamine (0.15 mg/kg), magnesium sulfate (30 mg/kg), a combination of both, or placebo 5 minutes before surgery.
• Standardized intraoperative analgesia included fentanyl and dexamethasone.

Main Results:

• No significant differences in postoperative pain scores were observed among the four groups.
• Ketamine and/or magnesium did not lead to reduced fentanyl use in the post-anesthesia recovery room or decreased 24-hour codeine consumption.
• No synergistic effect was noted between ketamine and magnesium. Incidence of nausea, vomiting, sedation, bleeding, or dreaming was similar across groups.

Conclusions:

• This study found no evidence that a small dose of ketamine and/or magnesium, when administered preoperatively, decreases pain or analgesic consumption in children undergoing tonsillectomy.
• The findings do not support the use of these NMDA receptor antagonists for acute postoperative pain management in this pediatric surgical context.